GlassScriptPhysician profile
Jesse P Parks
NPI 1578738621
$2,433.56
in general payments reported to CMS, 2019-2025
27 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $433 · 2021: $118 · 2022: $135 · 2023: $415 · 2024: $326 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,065.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $310.50 | 2020 | |
| Stryker Corporation | $251.34 | 2019-2025 | Variax, Dart-Fire, Ortholoc 2 Lapifuse |
| Biopro, INC. | $198.48 | 2023 | |
| Organogenesis INC. | $168.07 | 2019-2023 | Puraply |
| Medtronic, INC. | $155.48 | 2021-2022 | |
| Medtronic Vascular, INC. | $130.86 | 2019-2020 | |
| Smith+Nephew, INC. | $127.81 | 2019-2024 | Renasys Touch, Bioinductive Implant With Arthroscopic Delivery System - Medium, Memofix Super Elastic Nitinol Staple System |
| Horizon Therapeutics Plc | $127.65 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $99.08 | 2023-2025 | Nuzyra |
| Grt US Holding, INC. | $96.97 | 2021 | |
| Wright Medical Technology, INC. | $93.59 | 2019 | |
| Integra Lifesciences Corporation | $83.65 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bioventus LLC | $81.35 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Osiris Therapeutics INC. | $69.14 | 2019 | |
| Nuo Therapeutics | $66.64 | 2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $58.89 | 2023 | Cutimed Sorbact |
| Amgen INC. | $52.81 | 2025 | Krystexxa |
| Melinta Therapeutics, LLC | $48.40 | 2019-2023 | Orbactiv, Kimyrsa |
| Orthofix Medical, INC. | $47.95 | 2024 | Physio-Stim, Accelstim |
| Djo, LLC | $33.11 | 2025 | Cmf |
| Treace Medical Concepts, INC. | $27.73 | 2024 | |
| Solventum Corporation | $26.39 | 2025 | Promogran Prisma, V.A.C. Veraflo, Activ.A.C. |
| Kerecis Limited | $20.03 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Medartis INC. | $15.19 | 2019 | |
| Next Science LLC | $14.81 | 2024 | Blastx, Xperience, Surgx |
| Merck Sharp & Dohme LLC | $14.00 | 2019 | |
| Pfizer INC. | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Parks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.